过去三十年间的研究已经牢固地确定了纤溶系统是止血机制中不可缺少的组成部分。纤溶系统的紊乱可能有助于血栓形成。最近应用的两种纤溶酶原激活物——尿激酶(UK)和链激酶(SK)作为有前途的治疗药不仅激起了血栓形成领域中工作者们的极大兴趣,而且也引起了其他学科研究者们的注意。本文试图对这一领域提出广泛的展 Research over the past three decades has firmly established the fibrinolytic system as an integral part of the hemostatic mechanism. Disorders of the fibrinolytic system may contribute to thrombosis. Two recently used plasminogen activators, urokinase (UK) and streptokinase (SK), as promising therapeutic agents have not only aroused great interest among workers in the field of thrombosis but also caused Other disciplinary researchers’ attention. This article attempts to propose a broad exhibition of this area